Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
21 participants
INTERVENTIONAL
2011-06-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
NCT06154018
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005684
The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
NCT05006287
Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery
NCT00253851
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
NCT03140631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hepalean Heparin
Hepalean Heparin
400 units per kilogram bolus prior to initiation of CPB
PPC Heparin
PPC Heparin
400 unit per kilogram bolus prior to initiation of CPB
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hepalean Heparin
400 units per kilogram bolus prior to initiation of CPB
PPC Heparin
400 unit per kilogram bolus prior to initiation of CPB
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has provided written informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin H Teoh, MD
Role: PRINCIPAL_INVESTIGATOR
Hamilton Health Sciences: Hamilton General Site
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamilton Health Sciences: Hamilton General Hospital
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CANNeCTIN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.